Filter
1111
Filtered Results: 1111
Text search:
vaccine
trial
Featured
Recommendations
139
New Publications
237
Language
Document type
No document type
479
Studies & Reports
208
Guidelines
192
Manuals
68
Fact sheets
65
Strategic & Response Plan
41
Situation Updates
18
Training Material
14
Resource Platforms
12
Infographics
6
Videos
5
Brochures
2
App
1
Countries / Regions
Global
51
India
37
Kenya
26
Sierra Leone
25
South Africa
23
Liberia
21
Nigeria
21
West and Central Africa
18
Ethiopia
17
Western and Central Europe
17
Brazil
16
East and Southern Africa
16
Uganda
14
Africa
14
Latin America and the Carribbean
13
Congo, Democratic Republic of
11
Eastern Europe
11
Russia
10
Guinea
9
Ghana
9
Zambia
9
Ukraine
9
South Sudan
8
Rwanda
8
Malawi
8
Philippines
7
Nepal
7
Germany
7
Tanzania
7
Mozambique
7
Middle East and North Africa
7
South–East Asia Region
7
Zimbabwe
6
Syria
6
Bangladesh
6
Cambodia
4
Namibia
4
Myanmar / Burma
4
Asia
4
Vietnam
4
Burkina Faso
3
Senegal
3
USA
3
Lebanon
3
Thailand
3
Indonesia
3
Chile
3
Eastern Europe and Central Asia
3
Paraguay
3
United Kingdom
3
Guinea-Bissau
2
Cameroon
2
Jordan
2
Turkey
2
China
2
Sudan
2
Argentina
2
Botswana
2
Angola
2
Lesotho
2
Spain
2
Mali
1
Côte d’Ivoire / Ivory Coast
1
Morocco
1
Niger
1
Haiti
1
Pakistan
1
Iraq
1
Gambia
1
Malaysia
1
Papua New Guinea
1
Central African Republic
1
Peru
1
Eswatini/ Swaziland
1
Honduras
1
Ecuador
1
Yemen
1
Western Pacific Region
1
Venezuela
1
Southern Africa
1
Laos
1
Bulgaria
1
Gabon
1
Japan
1
France
1
Tunisia
1
Portugal
1
Authors & Publishers
Publication Years
Category
Countries
296
Clinical Guidelines
145
Women & Child Health
64
Public Health
58
Key Resources
23
Pharmacy & Technologies
14
Capacity Building
4
Toolboxes
COVID-19
282
TB
91
HIV
81
Ebola
67
Rapid Response
55
NTDs
44
AMR
31
Pharmacy
26
Global Health Education
16
Refugee
15
Mental Health
15
Planetary Health
14
Health Financing Toolbox
14
Conflict
12
NCDs
12
Polio
11
Zika
11
Caregiver
11
Cholera
10
Disability
2
Natural Hazards
1
These WHO interim recommendations on the use of the Pfizer – BioNTech BNT162b2 vaccine against Covid-19 were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary include...
nterim guidance, first issued 25 January 2021, updated 15 June 2021, updated 19 November 2021, updated 23 February 2022, updated 18 August 2022
AstraZeneca-SKBio in South Korea and Serum Institute of India
Interim recommendations for use of the inactivated COVID-19 vaccine, CoronaVac, developed by Sinovac
These WHO interim recommendations for use of the Sinovac-CoronaVac were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below.
This document has been updat...
This guidance document provides basic principles for a spokesperson of any health authority on how to respond to vocal vaccine deniers. The suggestions are based on psychological research on persuasion, on research in public health, communication st...
These WHO interim recommendations for use of the COVID-19 vaccine BIBP produced by Sinopharm were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the back...
Interim guidance, 26 October 2021
This interim guidance has been developed on the basis of the advice issued by the Strategic Advisory Group of Experts (SAGE) on Immunization at its meeting on 5 October 2021.
SAGE said moderately and severely immunocompromised persons should be offered an addition...
Overview
16 Dec 2021. This interim guidance pertains to heterologous primary and heterologous boosting schedules of Covid-19 vaccines. It focuses on heterologous schedules combining multiple vaccine platforms (e.g. a vectored ... followed by an mRNA vaccine).
Rabies is fatal, vaccine-preventable disease responsible for an estimated 59,000 human deaths each year. Most cases are transmitted by dogs, and most deaths occur in underserved populations in Africa and Asia. Approximately 40% of deaths occur in ch...
21 May 2021. he Practical Approach to Care Kit – PACK – is used by nurses, doctors and community health workers in their everyday work to care for patients at the clinic and in the community – PACK Adult, PACK Adolescent, PACK Child and PACK Community.
PACK Adult is also known as APC (Adult P...
This quick guide offers basic information about COVID-19, the Sinovac-CoronaVac COVID-19 vaccine and what to
expect following vaccination: ...
This was a Phase 3, multi-center, randomized, open-label, parallel-group, active control study where 273 male and female patients with first stage Trypanosoma brucei gambiense HAT were treated at six sites: one trypanosomiasis reference center in Angola, one hospital in South Sudan, and four hospita...
In April 2020, Gavi and COVAX joined the Access to COVID-19 Tools Accelerator (ACT-A) to provide equitable global access to COVID-19 vaccines to tackle the pandemic. In June 2020, the Gavi COVAX Advance Market Commitment (AMC) was launched to finance equitable access in 92 lower-income countries. Si...
